M Jane Luo Selected Research

4-azidophenylpropionamide

1/2018	Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1.
1/2017	Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Jane Luo Research Topics

Disease

1	Inflammation (Inflammations) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Neoplasms (Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017

Drug/Important Bio-Agent (IBA)

2	LY2584702IBA 01/2018 - 01/2017
2	4-azidophenylpropionamideIBA 01/2018 - 01/2017
1	dulaglutideIBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	tirzepatideIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Angiopoietin-like ProteinsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Threonine (L-Threonine)FDA Link 01/2018
1	oxidized low density lipoproteinIBA 01/2017